American Vanguard (NYSE:AVD) Stock Passes Above 200-Day Moving Average – Should You Sell?

American Vanguard Co. (NYSE:AVD) shares passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $5.91 and traded as high as $6.25. American Vanguard shares last traded at $6.20, with a volume of 216,179 shares changing hands.

American Vanguard Price Performance

The company’s 50-day moving average price is $5.21 and its 200-day moving average price is $5.89. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.79 and a current ratio of 1.89.

Insider Activity

In other news, Director Steven D. Macicek acquired 12,000 shares of the company’s stock in a transaction on Friday, November 15th. The shares were bought at an average price of $5.97 per share, with a total value of $71,640.00. Following the completion of the acquisition, the director now owns 31,218 shares in the company, valued at $186,371.46. This trade represents a 62.44 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 10.10% of the company’s stock.

Institutional Investors Weigh In On American Vanguard

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. SG Americas Securities LLC acquired a new position in shares of American Vanguard in the 3rd quarter valued at $56,000. Quantbot Technologies LP grew its position in American Vanguard by 64.5% during the 3rd quarter. Quantbot Technologies LP now owns 11,291 shares of the basic materials company’s stock worth $60,000 after purchasing an additional 4,429 shares during the last quarter. Quantinno Capital Management LP acquired a new position in American Vanguard in the third quarter valued at $89,000. Algert Global LLC purchased a new stake in shares of American Vanguard in the second quarter valued at about $158,000. Finally, XTX Topco Ltd purchased a new position in shares of American Vanguard during the third quarter worth about $104,000. Hedge funds and other institutional investors own 79.04% of the company’s stock.

American Vanguard Company Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.